← back to search

Liang Han

Qinghai University · CN

Area of research

Oncology · Pulmonary and Respiratory Medicine

Research interest

Research interests include Medicine, Lung cancer, Antibody, Lymphocyte, Immunology, and Antibody-drug conjugate.

h-index

—

citations

6

works

2

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

Phase I/II Study of Tifcemalimab, an Anti–B- and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer

Clinical Cancer Research 2025cited by 4position: middledoi

Results from a phase 1/2 study of 7MW3711: A novel B7-H3 antibody-drug conjugate (ADC) incorporating a topoisomerase I inhibitor in patients with lung cancer.

Journal of Clinical Oncology 2025cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2025–2025)Shun Lu · Ningbo University1 papers (2025–2025)Yu Yao · Henan Medical University1 papers (2025–2025)Qiming Wang · Nanjing University of Chinese Medicine1 papers (2025–2025)— · 1 papers (2025–2025)Ying Cheng · Changzhi University1 papers (2025–2025)Dongqing Lv · Nantong University1 papers (2025–2025)Bing Xia · Pennsylvania State University1 papers (2025–2025)Mingjun Shen · Guangxi Medical University1 papers (2025–2025)— · 1 papers (2025–2025)Peipei Wang · First Affiliated Hospital Zhejiang University1 papers (2025–2025)Qiming Wang · Hunan Cancer Hospital1 papers (2025–2025)Chong Li · New York University1 papers (2025–2025)Jie Wang · Qiqihar University1 papers (2025–2025)Jing Xu · Bioscience Research1 papers (2025–2025)Weiwei Ouyang · Guiyang Medical University1 papers (2025–2025)Ziming Li · Zhejiang University1 papers (2025–2025)Xiaoqing Liu · Fudan University1 papers (2025–2025)— · 1 papers (2025–2025)Shuhai Wang · Dongguan University of Technology1 papers (2025–2025)